top of page

MSK & Pain Commercialization & Contracting

MSK Cost Is Driven by Functional Recovery, Not Procedure Volume

Musculoskeletal cost curves are shaped by whether patients regain function — not by how much care they receive.

When MSK function improves, systems see:

  • Fewer spine and ortho surgical escalations

  • Lower advanced imaging utilization

  • Reduced opioid dependence

  • Shorter disability windows and faster return-to-work

When function does not improve, cost curves accelerate across:

  • Pain

  • Surgery

  • Disability claims

  • Mental health destabilization

  • Metabolic regression

MSK has become one of the largest financial leverage points in commercial and MA populations.
The question is no longer how care is delivered — the question is whether patients recover function over time.

​

Why MSK Strategies Stall Inside Systems

MSK crosses orthopedic surgery, PT/OT, primary care, pain medicine, behavioral health, and metabolic care.

But inside systems, these functions sit in separate silos:

  • Orthopedics owns procedures and surgical planning, not continuity.

  • PT/OT owns session delivery, not compliance over time.

  • Pain Management owns medication strategy, not behavioral engagement.

  • Primary Care owns comorbidities, not functional recovery.

  • Behavioral Health owns stabilization, not MSK progression.

  • Finance sees the costs, but not the clinical levers that move them.

Each group influences MSK outcomes.
No one owns the cost curve.

​

The Shift in 2026

Payers are no longer contracting for:

  • Generic “digital MSK”

  • PT access expansion

  • “Pain support programs”

  • Single-condition pilots

They are contracting for:

  • Functional recovery

  • Surgical avoidance

  • Fewer disability days

  • Reduced recurrence

  • Lower total cost of care over 6–18 months

This requires continuity, not episodic care.

​

What Axis Does

Axis designs contracting and commercialization models that position MSK as a functional recovery system, not a siloed service line.

We align:

  • Behavioral stabilization (engagement + coping capacity)

  • Metabolic support (weight, inflammation, and movement tolerance)

  • MSK progression (strength, load, mobility, gait, and return-to-function)

Into a single performance and reimbursement architecture
that payers and systems can evaluate, fund, and scale.

​

How We Work

  1. Define MSK Population & Cohort Criteria
    Identify the right patients where functional recovery drives cost curve improvement.

  2. Establish Progression & Recovery Milestones
    Measurable functional objectives — not generic pain reduction.

  3. Align Behavioral & Metabolic Continuity
    Ensure patients can complete the MSK progression arc.

  4. Build Claims-Linked Evidence Models
    Show escalation avoidance, disability reduction, and return-to-work lift.

  5. Price & Negotiate the Contract Structure
    PMPM, case rates, or value-based upside tied to functional milestones.

​

The Outcomes We Deliver

Organizations see:

  • Lower orthopedic and spine surgical escalation

  • Reduced MRI and injection utilization

  • Reduced opioid exposure and relapse probability

  • Measurable improvement in return-to-work timelines

  • A defensible narrative for payer renewals and expansion

This positions MSK not as a volume strategy, but as a margin and cost recovery strategy.

​

Why Systems and Plans Bring in Axis

Because functional recovery sits across multiple service lines — and no internal leader is accountable for the whole MSK cost curve.

Axis functions as the Commercialization Architect:

  • We define the clinical + operational + financial alignment.

  • We build the contracting logic so value is recognized in pricing.

  • We prepare the renewal and expansion narrative executives need to defend.

You are no longer selling “MSK services.”
You are selling measurable cost curve stabilization.

​

If You’re at a Strategic Inflection Point

This page is for you if:

  • Surgical escalation rates are rising

  • MSK disability claims are eroding employer relationships

  • Digital MSK or PT programs are not converting into measurable savings

  • Your teams are delivering care, but not proving value

  • You need a defensible contracting story before renewal cycle

If that sounds familiar — you are ready.

​

Call to Action

Let’s Architect What’s Next.
Schedule a 30-minute Executive Briefing to evaluate your MSK contracting and renewal leverage position.

​

Tom
Founder & Commercialization Architect
Axis Growth Partners
tomriley@axisgrowthpartners.co
axisgrowthpartners.co

bottom of page